Tower Research Capital LLC (Trc) Immunovant, Inc. Transaction History

Tower Research Capital LLC (Trc)

  • $3.68 Billion
  • Q3 2024

A detailed history of Tower Research Capital LLC (Trc) transactions in Immunovant, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 1,016 shares of IMVT stock, worth $27,950. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,016
Previous 14,142 92.82%
Holding current value
$27,950
Previous $373,000 92.76%
% of portfolio
0.0%
Previous 0.01%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$27.51 - $27.51 $361,096 - $361,096
-13,126 Reduced 92.82%
1,016 $27,000
Q2 2024

Aug 13, 2024
BUY
$25.1 - $31.61 $342,113 - $430,844
13,630 Added 2662.11%
14,142 $373,000
Q1 2024

May 15, 2024
SELL
$30.27 - $43.79 $207,743 - $300,530
-6,863 Reduced 93.06%
512 $16,000
Q4 2023

Feb 13, 2024
SELL
$31.31 - $44.19 $70,541 - $99,560
-2,253 Reduced 23.4%
7,375 $310,000
Q3 2023

Nov 14, 2023
BUY
$18.55 - $39.96 $145,654 - $313,765
7,852 Added 442.12%
9,628 $369,000
Q2 2023

Aug 14, 2023
SELL
$14.2 - $23.75 $270,155 - $451,843
-19,025 Reduced 91.46%
1,776 $33,000
Q1 2023

May 09, 2023
BUY
$15.27 - $19.72 $268,049 - $346,164
17,554 Added 540.62%
20,801 $322,000
Q4 2022

Feb 10, 2023
SELL
$6.59 - $17.75 $55,593 - $149,739
-8,436 Reduced 72.21%
3,247 $58,000
Q3 2022

Nov 10, 2022
BUY
$3.93 - $6.37 $23,277 - $37,729
5,923 Added 102.83%
11,683 $65,000
Q2 2022

Aug 15, 2022
SELL
$3.38 - $5.65 $15,784 - $26,385
-4,670 Reduced 44.77%
5,760 $22,000
Q1 2022

May 12, 2022
BUY
$5.06 - $8.77 $12,609 - $21,854
2,492 Added 31.39%
10,430 $57,000
Q4 2021

Feb 14, 2022
SELL
$7.33 - $9.32 $17,218 - $21,892
-2,349 Reduced 22.83%
7,938 $67,000
Q3 2021

Nov 15, 2021
BUY
$7.01 - $11.37 $43,462 - $70,494
6,200 Added 151.7%
10,287 $89,000
Q2 2021

Aug 16, 2021
SELL
$9.4 - $16.85 $15,594 - $27,954
-1,659 Reduced 28.87%
4,087 $43,000
Q1 2021

May 17, 2021
BUY
$13.08 - $49.6 $43,111 - $163,481
3,296 Added 134.53%
5,746 $92,000
Q4 2020

Feb 16, 2021
SELL
$36.36 - $52.71 $54,394 - $78,854
-1,496 Reduced 37.91%
2,450 $113,000
Q3 2020

Nov 16, 2020
BUY
$22.61 - $38.9 $65,365 - $112,459
2,891 Added 274.03%
3,946 $139,000
Q2 2020

Aug 13, 2020
BUY
$13.87 - $28.44 $14,632 - $30,004
1,055 New
1,055 $26,000

Others Institutions Holding IMVT

# of Institutions
211
Shares Held
66M
Call Options Held
2.3M
Put Options Held
631K
View Full List

About Immunovant, Inc.

IMVT Quotes by TradingView
  • Ticker IMVT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 129,077,000
  • Market Cap $3.55B
  • Description
  • Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in Phase IIa clinical trials for the treatment of mya...
More about IMVT
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email